Anomalies beyond sites of chromatic opponency contribute to sensitivity losses of an S-cone pathway in diabetes

B. E. Schefrin, A. J. Adams, John S Werner

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Threshold vs radiance (tvr) functions and the loci of spectral unique blue and unique green were measured for six diabetic subjects and four age-matched controls. The tvr functions provided an indication of cone-sensitivity losses of diabetics compared to controls, while the unique hue loci were used to assess relative cone contributions to chromatic-opponent pathways. If the sensitivity losses of S-cone pathways observed in diabetic subjects were due only to anomalies before the sites of chromatic opponency, current models of chromatic pathways would predict that unique blue and unique green should be shifted towards shorter wavelengths relative to control subjects. With one exception, the unique hue loci for all tested diabetic subjects, including those with relatively large sensitivity losses of their short-wavelength-sensitivity (S-) cone pathways, fell within the range of unique hue loci for the controls. The results are consistent with the hypothesis that diabetes produces a defect beyond the sites that encode the sensations of unique blue and unique green within chromatically-opponent pathways.

Original languageEnglish (US)
Pages (from-to)219-228
Number of pages10
JournalClinical Vision Sciences
Volume6
Issue number3
StatePublished - 1991
Externally publishedYes

Fingerprint

Color
Internal-External Control

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Anomalies beyond sites of chromatic opponency contribute to sensitivity losses of an S-cone pathway in diabetes. / Schefrin, B. E.; Adams, A. J.; Werner, John S.

In: Clinical Vision Sciences, Vol. 6, No. 3, 1991, p. 219-228.

Research output: Contribution to journalArticle

@article{ee3a6f28e8524dd89e0e34544834dd29,
title = "Anomalies beyond sites of chromatic opponency contribute to sensitivity losses of an S-cone pathway in diabetes",
abstract = "Threshold vs radiance (tvr) functions and the loci of spectral unique blue and unique green were measured for six diabetic subjects and four age-matched controls. The tvr functions provided an indication of cone-sensitivity losses of diabetics compared to controls, while the unique hue loci were used to assess relative cone contributions to chromatic-opponent pathways. If the sensitivity losses of S-cone pathways observed in diabetic subjects were due only to anomalies before the sites of chromatic opponency, current models of chromatic pathways would predict that unique blue and unique green should be shifted towards shorter wavelengths relative to control subjects. With one exception, the unique hue loci for all tested diabetic subjects, including those with relatively large sensitivity losses of their short-wavelength-sensitivity (S-) cone pathways, fell within the range of unique hue loci for the controls. The results are consistent with the hypothesis that diabetes produces a defect beyond the sites that encode the sensations of unique blue and unique green within chromatically-opponent pathways.",
author = "Schefrin, {B. E.} and Adams, {A. J.} and Werner, {John S}",
year = "1991",
language = "English (US)",
volume = "6",
pages = "219--228",
journal = "Vision Research",
issn = "0042-6989",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Anomalies beyond sites of chromatic opponency contribute to sensitivity losses of an S-cone pathway in diabetes

AU - Schefrin, B. E.

AU - Adams, A. J.

AU - Werner, John S

PY - 1991

Y1 - 1991

N2 - Threshold vs radiance (tvr) functions and the loci of spectral unique blue and unique green were measured for six diabetic subjects and four age-matched controls. The tvr functions provided an indication of cone-sensitivity losses of diabetics compared to controls, while the unique hue loci were used to assess relative cone contributions to chromatic-opponent pathways. If the sensitivity losses of S-cone pathways observed in diabetic subjects were due only to anomalies before the sites of chromatic opponency, current models of chromatic pathways would predict that unique blue and unique green should be shifted towards shorter wavelengths relative to control subjects. With one exception, the unique hue loci for all tested diabetic subjects, including those with relatively large sensitivity losses of their short-wavelength-sensitivity (S-) cone pathways, fell within the range of unique hue loci for the controls. The results are consistent with the hypothesis that diabetes produces a defect beyond the sites that encode the sensations of unique blue and unique green within chromatically-opponent pathways.

AB - Threshold vs radiance (tvr) functions and the loci of spectral unique blue and unique green were measured for six diabetic subjects and four age-matched controls. The tvr functions provided an indication of cone-sensitivity losses of diabetics compared to controls, while the unique hue loci were used to assess relative cone contributions to chromatic-opponent pathways. If the sensitivity losses of S-cone pathways observed in diabetic subjects were due only to anomalies before the sites of chromatic opponency, current models of chromatic pathways would predict that unique blue and unique green should be shifted towards shorter wavelengths relative to control subjects. With one exception, the unique hue loci for all tested diabetic subjects, including those with relatively large sensitivity losses of their short-wavelength-sensitivity (S-) cone pathways, fell within the range of unique hue loci for the controls. The results are consistent with the hypothesis that diabetes produces a defect beyond the sites that encode the sensations of unique blue and unique green within chromatically-opponent pathways.

UR - http://www.scopus.com/inward/record.url?scp=0025809972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025809972&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0025809972

VL - 6

SP - 219

EP - 228

JO - Vision Research

JF - Vision Research

SN - 0042-6989

IS - 3

ER -